Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
May 18 JNJ Novo Nordisk, J&J lead R&D rankings in big pharma: report
May 18 JNJ Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18 JNJ Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO
May 17 JNJ Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
May 17 JNJ J&J-backed startup Rapport files for US IPO
May 17 REGN More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
May 17 JNJ J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
May 17 MESO Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
May 17 CAPR Capricor Therapeutics stock rises, Oppenheimer initiates coverage at Outperform
May 17 REGN Regeneron wins temporary restraining order preventing Eylea generic launch
May 17 JNJ Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more
May 16 JNJ Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
May 16 JNJ Johnson & Johnson to Buy Proteologix For $850 Million in Cash
May 16 JNJ Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
May 16 JNJ Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors
May 16 JNJ Johnson & Johnson to buy dermatology-focused biotech Proteologix
May 16 JNJ UPDATE 1-Johnson & Johnson to acquire Proteologix for $850 million
May 16 JNJ Johnson & Johnson to acquire Proteologix for $850 million
May 16 JNJ Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
May 16 REGN These 2 No-Brainer Growth Stocks Are Breaking New Ground
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags